Previous research has revealed that genetic alterations accumulated in HCC were numerous, and specific genetic alterations may promote tumorigenesis (El Tekle et al., 2021), so we investigated whether RAB42 mutation may play a critical role in hepatocarcinogenesis. This evidence concerns the gene RAB42 and hepatocellular carcinoma.